Microbiological Enumeration of Pathogens Associated with Urinary Tract Infection: Current Scenario and Its Medical Relevance

Main Article Content

Pooja Singh
Jyoti Chandola
Manoj Singh Shahi
Narotam Sharma
Komal Gupta
Sandeep Singh

Abstract

Background: Urinary tract infection (UTI) is the most common among community acquired infections worldwide affecting men as well as women, many reports suggested that uropathogens are becoming more resistant towards antibiotics, which can cause various problems during treatment.

Methods: In this study, 48 samples were collected from the suspected patients and these samples were subjected to various clinical evaluations.

Results: Among them 29 were females and 19 were males, in the studied cases E. coli (48.3%) was most frequently observed pathogens, S. aureus (29.03%).Among antibiotics, Tigecyclin (TGC) was the most effective antibiotic against all the three isolated bacteria, about 100% of bacteria showed the sensitivity towards it. E. coli was found to be the  most resistant bacteria against Tetracycline (TET) (66.6%) followed by Amoxiclav (AMC) (60%), Fosfomycin (Fo) (53.3%), Piperacilllin (PIP) (53.3%), Cefepime (CPM) (53.3%). Among K. pneumonia isolates had shown resistance against Tetracycline (TET) (57.1%), Fosfomycin (FO) (57.1%), Piperacillin (PI) (57.1%), Cephalexin (CZ) (57.1%) and Amikacin (AK) (57.1%). Staphylococcus aureus had shown maximum resistance against Tetracycline (TET) (66.5%), Co-amoxiclav (AMC) (66.5%) followed by Chloramphenicol (55.4%) and Cefepime (CPM) (55.4%).

Conclusion: In conclusion UTI infection rates are higher among females, E. coli was the most causative agents of UTI and the emergence of resistance in bacteria is probably due to the overuse of antibiotics. Antibiotic Tigecyclin could be the drug of choice for the treatment of UTI.

Keywords:
Urinary tract infection, uropathogens, clinical evaluation, antibiotics, emergence.

Article Details

How to Cite
Singh, P., Chandola, J., Shahi, M. S., Sharma, N., Gupta, K., & Singh, S. (2021). Microbiological Enumeration of Pathogens Associated with Urinary Tract Infection: Current Scenario and Its Medical Relevance. Asian Journal of Medicine and Health, 18(12), 26-31. https://doi.org/10.9734/ajmah/2020/v18i1230282
Section
Original Research Article

References

Delanghe JR, Kouri TT, Huber AR, Hannemann-Pohl K, Guder WG, Lun A, et al. The role of automated urine particle flow cytometry in clinical practice. Clinica Chimica Acta. 2000;301(1-2):1-8.

Khadri H, Alzohairy M. High prevalence of multi-drug-resistance (MDR) and extended spectrum β-lactamases (ESBL) producing bacteria among community-acquired urinary tract infections (CAUTI). Journal of Bacteriology Research. 2009;1(9):105-110.

Kant S, Misra P, Gupta S, Goswami K, Krishnan A, Nongkynrih B, et al. The ballabgarh health and demographic surveillance system (CRHSP-AIIMS). International Journal of Epidemiology. 2013;42(3):758-768.

Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7(12): 653-60.

Kausar A, Akram M, Shoaib M, Mehmood RT, Abbasi MN, Adnan M, et al. Isolation and identification of UTI causing agents and frequency of ESBL (extended spectrum beta lactamase) in Pakistan. Amer J Phytomed Clin Ther. 2014;2:963-975.

Thakur S, Pokhrel N, Sharma M. Prevalence of multidrug resistant enterobacteriaceae and extended spectrum β lactamase producing escherichia coli in urinary tract infection. Res J Pharm Biol Chem Sci. 2013;4(2): 1615.

Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45(4):493–6.

CLSI. Performance standards for antimicrobial disk tests; Approved standards. 25th edition. Clinical and Laboratory Standards Institute (CLSI) Document M2-A9. Wayne. 2016;26(1).

Ronald A. The etiology of urinary tract infection: Traditional and emerging pathogens. The American Journal of Medicine. 2002;113(1):14-9.

Castro-Orozco R, Barreto-Maya AC, Guzmán-Álvarez H, Ortega-Quiroz RJ, Benítez-Peña L. Antimicrobial resistance pattern for gram-negative uropathogens isolated from hospitalised patients and outpatients in Cartagena, 2005-2008. Revista de Salud Publica. 2010;12(6): 1010-9.

Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in JNMC Hospital Aligarh, India. Annals of Clinical Microbiology and Antimicrobials. 2007;6(1):4.

Karlowsky JA, Jones ME, Thornsberry C, Critchley I, Kelly LJ, Sahm DF. Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999. International Journal of Antimicrobial Agents. 2001;18(2):121-7.

Oladeinde BH, Omoregie R, Olley M, Anunibe JA. Urinary tract infection in a rural community of Nigeria. North American Journal of Medical Sciences. 2011;3(2):75.

Manjunath GN, Prakash R, Vamseedhar Annam KS. Changing trends in the spectrum of antimicrobial drug resistance pattern of uropathogens isolated from hospitals and community patients with urinary tract infections in Tumkur and Bangalore. Int J Biol Med Res. 2011; 2(2):504-7.

Rakesh K, Dahiya SS, Kirti H, Preeti S. Isolation of human pathogenic bacteria causing urinary tract infection and their antimicrobial susceptibility pattern in a tertiary care hospital, Jaipur, India. Int Res J Med Sci. 2014;2:6-10.

Zhanel GG, Hisanaga TL, Laing NM, DeCorby MR, Nichol KA, Weshnoweski B, et al. Antibiotic resistance in escherichia coli outpatient urinary isolates: Final results from the North American urinary tract infection collaborative alliance (NAUTICA). International Journal of Antimicrobial Agents. 2006;27(6):468-75.